SEQUVAX
Live / Applied — Second extension granted (statement of use) (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 05 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98585952
- Mark type
- Stylized text
- Filed
- 05 Jun 2024
- Published for opposition
- 14 Jan 2025
- Attorney of record
- Nancy Sabarra
Goods and services
- Class 042 — Scientific and technological services: Providing medical and scientific research information about the results of clinical trials for coronavirus and COVID-19 vaccines; providing medical and scientific research information in the field of coronavirus and COVID-19 vaccines and coronavirus and COVID-19 vaccine clinical trials.
Owner
- Seqirus UK Limited, Maidenhead, Berkshire, GB
- Seqirus UK Limited, Maidenhead, Berkshire, GB
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 2 GRANTED
- 24 Feb 2026 — SOU EXTENSION 2 FILED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2025 — SOU EXTENSION 1 GRANTED
- 09 Sept 2025 — SOU EXTENSION 1 FILED
- 09 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Dec 2024 — ASSIGNED TO EXAMINER
- 17 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED